Published in Br Med J on May 03, 1975
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study. Am J Public Health (1982) 1.65
Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) (1983) 1.53
Serum lipids in young female survivors of myocardial infarction. Br Heart J (1975) 1.31
Prevalence of three major risk factors in random sample of men and women, and in patients with ischaemic heart disease. Br Heart J (1978) 1.24
Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. Am J Public Health (1978) 1.21
The "top 50": a perspective on the BMJ drawn from the Science Citation Index. BMJ (1990) 1.07
Reproductive history, socioeconomic status, and self-reported health status of women aged 50 years or older. Am J Public Health (1997) 1.00
Pharmacoepidemiology: a new discipline. Br Med J (Clin Res Ed) (1984) 0.99
Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age. Can Med Assoc J (1977) 0.92
Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest (1982) 0.91
Oral contraceptive use and venous thromboembolism: absence of an effect of smoking. Br Med J (1977) 0.86
Transmural myocardial infarction in young women taking oral contraceptives. Evidence of reduced regional coronary flow in spite of normal coronary arteries. Br Heart J (1977) 0.81
Immunogenicity and the vascular risk of oral contraceptives. Br Heart J (1985) 0.77
The role of estrogens as a risk factor for stroke in postmenopausal women. West J Med (1980) 0.76
Anti-oestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus. Clin Exp Immunol (1987) 0.76
Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects. Br J Clin Pharmacol (1979) 0.75
Ischaemic heart disease in young hypertensive women. Br Heart J (1980) 0.75
[Desogestrel contraceptives: the perfect pill for lipids?]. Can Fam Physician (1996) 0.75
A woman's heart. An update of coronary artery disease risk in women. West J Med (1988) 0.75
Clinical implications of Surgeon General's Report on Smoking and Health. J Natl Med Assoc (1979) 0.75
Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J (1968) 11.26
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J (1970) 6.82
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet (1972) 4.54
Smoking habits of oral contraceptive users. Lancet (1969) 4.20
Oral contraceptives and death from myocardial infarction. Br Med J (1975) 3.12
Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94
Ischaemic heart disease in young women. Br Med J (1974) 1.63
Serum-lipids in women on oral contraceptives. Lancet (1971) 1.29
Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin. Br J Prev Soc Med (1974) 1.12
Coronary heart disease in women. Study of risk factors in 100 patients less than 60 years of age. Circulation (1967) 1.09
Thromboembolism, cancer, and oral contraceptives. Clin Obstet Gynecol (1974) 1.08
Characteristics of women using different methods of contraception--some preliminary findings from a prospective study. Int J Epidemiol (1972) 0.99
Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J (1968) 11.26
Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J (1968) 9.17
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J (1970) 6.82
Interventions for promoting physical activity. Cochrane Database Syst Rev (2005) 5.83
Rising incidence of fracture of the proximal femur. Lancet (1985) 4.83
Prescribing exercise in general practice. BMJ (1994) 4.73
Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J (1969) 4.50
Strategies for reducing coronary risk factors in primary care: which is most cost effective? BMJ (1995) 4.36
Cost-effectiveness of a primary care based physical activity intervention in 45-74 year old men and women: a randomised controlled trial. Br J Sports Med (1998) 4.23
Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chronic Dis (1975) 4.17
A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 4.12
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet (1983) 3.53
The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract (2001) 3.48
Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J (1978) 3.20
Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand. N Z Med J (1993) 3.18
Oral contraceptives and death from myocardial infarction. Br Med J (1975) 3.12
Lack of willpower or lack of wherewithal? "Internal" and "external" barriers to changing diet and exercise in a three year follow-up of participants in a health check. Soc Sci Med (1998) 3.10
The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer (1988) 3.07
Diagnosing insulin resistance in the general population. Diabetes Care (2001) 3.06
A randomised controlled trial of surgery for glue ear. BMJ (1990) 2.93
Risk of venous thromboembolism in users of hormone replacement therapy. Lancet (1996) 2.92
Randomised controlled trials of physical activity promotion in free living populations: a review. J Epidemiol Community Health (1995) 2.91
Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed) (1983) 2.90
A community study of diabetes in Oxfordshire. J R Coll Gen Pract (1983) 2.88
Oral contraceptives and breast neoplasia: a retrospective study. Br Med J (1972) 2.81
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia (2004) 2.66
Lifestyle advice in general practice: rates recalled by patients. BMJ (1992) 2.64
A systematic review of physical activity promotion strategies. Br J Sports Med (1996) 2.63
Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet (1981) 2.63
Evaluation of computer support for prescribing (CAPSULE) using simulated cases. BMJ (1997) 2.61
Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ (1996) 2.61
Outcome of pregnancy in women using an intrauterine device. Lancet (1974) 2.58
Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ (1996) 2.58
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract (1995) 2.56
Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet (1975) 2.46
Symptomless diverticular disease and intake of dietary fibre. Lancet (1979) 2.45
Fertility after stopping different methods of contraception. Br Med J (1978) 2.40
Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed) (1982) 2.40
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer (1987) 2.35
A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet (1981) 2.35
Mortality of gasworkers - final report of a prospective study. Br J Ind Med (1972) 2.31
The carrot, the stick and the general practitioner: how have changes in financial incentives affected health promotion activity in general practice? Br J Gen Pract (1995) 2.29
Study of symptoms in middle life with special reference to the menopause. Br Med J (1980) 2.24
Health promotion in primary care. BMJ (1996) 2.22
Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke (2004) 2.22
Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception (1987) 2.21
The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review. Br J Obstet Gynaecol (1998) 2.18
Preliminary evaluation of four oral contraceptives containing only progestogens. Br Med J (1969) 2.16
Oral contraceptives and breast cancer. Lancet (1983) 2.16
The care of oral contraceptive users by general practitioners in Oxfordshire. J R Coll Gen Pract (1977) 2.14
Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968-1976: evidence of an increasing incidence. Diabetologia (1983) 2.12
Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health (1997) 2.08
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report. Q J Med (1985) 2.07
Cardiovascular risk and attitudes to lifestyle: what do patients think? BMJ (1993) 2.07
Lipid screening: is it enough to measure total cholesterol concentration? BMJ (1990) 2.06
Postoperative thromboembolism and the use of oral contraceptives. Br Med J (1970) 2.04
The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med (1988) 2.03
Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract (1990) 2.02
Oral contraceptive use in older women and fatal myocardial infarction. Br Med J (1976) 2.01
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
Chronic pelvic pain in the community--symptoms, investigations, and diagnoses. Am J Obstet Gynecol (2001) 2.01
An investigation of risk factors for symptomatic osteoarthritis of the knee in women using a life course approach. J Epidemiol Community Health (2003) 1.99
Desire for the body normal: body image and discrepancies between self reported and measured height and weight in a British population. J Epidemiol Community Health (1996) 1.96
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J (Clin Res Ed) (1987) 1.91
Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer (1982) 1.90
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
Dietary determinants of ischaemic heart disease in health conscious individuals. Heart (1997) 1.87
Triglyceride fatty acids confirm a change in dietary fat. Clin Endocrinol (Oxf) (1977) 1.86
Mortality among women participating in the Oxford/Family Planning Association contraceptive study. Lancet (1977) 1.83
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80
Occupational hazards of anesthesia. Br Med J (1980) 1.79
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. Br Med J (Clin Res Ed) (1985) 1.78
Cereal grains, legumes and diabetes. Eur J Clin Nutr (2004) 1.77
Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75
The Oxford Vegetarian Study: an overview. Am J Clin Nutr (1999) 1.75
Epidemiological studies of the occupational hazards of anaesthesia--a review. Anaesthesia (1978) 1.75
Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev (2007) 1.71
Death from ischaemic heart disease. Br Med J (1977) 1.70
A long-term study of mortality in men who have undergone vasectomy. N Engl J Med (1992) 1.70
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut (2000) 1.69